Related Experiment Videos

Evaluation of disease severity in familial Mediterranean fever

Adam Mor1, Yael Shinar, Nurit Zaks

  • 1Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Seminars in Arthritis and Rheumatism
|August 9, 2005
PubMed
Abstract

Insights

Researchers developed a new objective severity score for familial Mediterranean fever (FMF). This FMF-severity score (F-SS) accurately differentiates disease severity, aiding treatment and prognosis.

Area of Science:

  • Rheumatology
  • Genetics
  • Clinical Medicine

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease.
  • Accurate disease severity assessment is crucial for FMF management.
  • Existing FMF severity measures lack objectivity and statistical validation.

Purpose of the Study:

  • To develop a novel, objective, and statistically validated severity score for FMF.
  • To create a tool for differentiating between mild, intermediate, and severe FMF cases.
  • To enhance FMF patient stratification for clinical decision-making.

Main Methods:

  • Evaluation of 100 consecutive FMF patients by two independent experts.
  • Assignment of patients into mild, intermediate, or severe categories.
  • Analysis of nine objective criteria (attack frequency, affected sites, duration) using a classification-tree model.

Main Results:

  • Frequency of attacks, number of affected sites, and attack duration were key differentiating criteria.
  • A new FMF-severity score (F-SS-1) demonstrated high sensitivity and specificity.
  • A simplified score (F-SS-2) was developed by integrating clinical parameters with F-SS-1.

Conclusions:

  • The established FMF-severity scores (F-SS) are objective, valid, and accurately distinguish FMF severity levels.
  • These scores can significantly aid in treatment decisions, prognosis evaluation, and population-based research.
  • The F-SS provides a valuable tool for standardized FMF assessment.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...